DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



EXCEL Clinical Trial (Universal Registry)

Information source: Abbott Vascular
Information obtained from ClinicalTrials.gov on October 04, 2010
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Chronic Coronary Occlusion; Stent Thrombosis; Vascular Disease; Myocardial Ischemia; Coronary Artery Stenosis; Coronary Disease; Coronary Artery Disease; Coronary Restenosis

Phase: N/A

Status: Not yet recruiting

Sponsored by: Abbott Vascular

Official(s) and/or principal investigator(s):
Gregg W Stone, MD, Principal Investigator, Affiliation: Columbia University
Patrick W Serruys, MD, Principal Investigator, Affiliation: Erasmus Medical Center
Joseph Sabik, MD, Principal Investigator, Affiliation: Cleveland Clinical Main Campus
A. Pieter Kappetein, MD, Principal Investigator, Affiliation: Erasmus Medical Center

Overall contact:
Ali Kakavand, Phone: 408-845-2012, Email: ali.kakavand@av.abbott.com

Summary

The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized; to compare the baseline characteristics of subjects; and to assess the variability in randomization eligibility and treatment patterns.

Clinical Details

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: This study has no Primary outcome measure, it is an observational study to collect information on subjects not randomized to the RCT portion of the study.

Detailed description: Approximately 100 consecutive subjects who otherwise meet all enrollment criteria, will be analyzed separately as intermediate lesion subjects, and will be followed through the time of initial treatment per standard of care with intended PCI, CABG or medical treatment.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Subjects who are either not eligible for randomization or for other reasons are not

randomized will be consented for the Universal Registry

Locations and Contacts

Ali Kakavand, Phone: 408-845-2012, Email: ali.kakavand@av.abbott.com

Abbott Vascular, Santa Clara, California 95054, United States
Additional Information

Starting date: September 2010
Last updated: September 17, 2010

Page last updated: October 04, 2010

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012